Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer

Mutlu, HASAN; Musri, FATMA; Artac, Mehmet; KARGI, Aysegul; OZDOGAN, Mustafa; BOZCUK, Hakan

doi:10.4103/0973-1482.154008

Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer

Mutlu H., Musri F., Artac M., KARGI A., OZDOGAN M., BOZCUK H.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.11, sa.2, ss.287-290, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 11 Sayı: 2
Basım Tarihi: 2015
Doi Numarası: 10.4103/0973-1482.154008
Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.287-290
Anahtar Kelimeler: Breast cancer, heavily treated, metronomic, survival, PHASE-III TRIAL, CYCLOPHOSPHAMIDE, COMBINATION, CAPECITABINE, BENEFIT, ANTHRACYCLINE, BEVACIZUMAB, ETOPOSIDE, SURVIVAL, DOXORUBICIN
Akdeniz Üniversitesi Adresli: Evet

Özet

Background: We aimed to assess the efficacy of a metronomic regimen with cyclophosphamide and etoposide in heavily treated patients with metastatic breast cancer (MBC).